Influence of Rictor and Raptor Expression of mTOR Signaling on Long-Term Outcomes of Patients with Hepatocellular Carcinoma. (Q51037580)

27 March 2018

title

Influence of Rictor and Raptor Expression of mTOR Signaling on Long-Term Outcomes of Patients with Hepatocellular Carcinoma. (English)

1 reference

27 March 2018

author name string

Masaki Kaibori

1

1 reference

27 March 2018

Nobuaki Shikata

2

1 reference

27 March 2018

Tatsuma Sakaguchi

3

1 reference

27 March 2018

Morihiko Ishizaki

4

1 reference

27 March 2018

Kosuke Matsui

5

1 reference

27 March 2018

Hiroya Iida

6

1 reference

27 March 2018

Yoshito Tanaka

7

1 reference

27 March 2018

Hirokazu Miki

8

1 reference

27 March 2018

Richi Nakatake

9

1 reference

27 March 2018

Tadayoshi Okumura

10

1 reference

27 March 2018

Katsuji Tokuhara

11

1 reference

27 March 2018

Kentaro Inoue

12

1 reference

27 March 2018

Jouji Wada

13

1 reference

27 March 2018

Michio Oda

14

1 reference

27 March 2018

Mikio Nishizawa

15

1 reference

27 March 2018

Masanori Kon

16

1 reference

27 March 2018

publication date

5 November 2014

1 reference

27 March 2018

Digestive Diseases and Sciences

published in

1 reference

27 March 2018

volume

60

1 reference

27 March 2018

issue

4

1 reference

27 March 2018

page(s)

919-928

1 reference

27 March 2018

Epidemiology of primary liver cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

The biology and clinical relevance of the PTEN tumor suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Dysregulation of the TSC-mTOR pathway in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

mTOR-targeted therapy of cancer with rapamycin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

21 January 2018

mTOR and cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

The TOR pathway: a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

mTOR and P70 S6 kinase expression in primary liver neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, while tacrolimus promotes cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Pivotal role of mTOR signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Simple technique for detecting RNA viruses by PCR in single sections of wax embedded tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

A novel method for real time quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Updates of mTOR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3417-7

Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes.

21 January 2018

1 reference

12 December 2020

Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition

1 reference

12 December 2020

Increase in primary liver cancer in the UK, 1979-94

1 reference

12 December 2020

Gene expression signature of the gross morphology in hepatocellular carcinoma

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors

1 reference

12 December 2020

10.1007/S10620-014-3417-7

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018